Histone-modified Prussian blue nanoparticles for efficient photothermal cancer therapy via nucleus targeting
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (9)
Show source-provided references
1. Clinical development and potential of photo thermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
2. Gold nanoshell-localized photo thermal ablation of prostate tumors in a clinical pilot device study10.1073/pnas.1906929116 ↗
3. Photo thermal therapy: from encouraging lab results to lackluster clinical translation
4. PEGylated Prussian blue nanocubes as a theranostic agent for simultaneous cancer imaging and photo thermal therapy10.1016/j.biomaterials.2014.09.004 ↗
5. Advancements of Prussian blue-based nanoplatforms in biomedical fields: progress and perspectives10.1016/j.jconrel.2022.10.007 ↗
6. Boosting theranostic performance of AIEgens using nanocatalyzer for robust cancer immunotherapy
7. Nanoparticle based direct nucleus delivery platform for synergistic cancer therapy10.1002/anie.201900884 ↗
8. Engineered exosome-mediated near-infrared-II region V2C quantum dot delivery for nucleus-target low-temperature photo thermal therapy
9. A tumor-penetrable drug nanococktail made from human histones for interventional nucleus-targeted chemophotothermal therapy of drug-resistant tumors